dpp 4 inhibitor and glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Mechanism of action of DPP-4

Description

These drugs can improve metabolic health, reducing inflammation and insulin resistance, which are risk factors for CRC

Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects

GLP-1 Monitoring with Vitals Package/GLP-1 Package with Vitals (Includes all 72 tests above + 4 vital parameters) Vitals: These track weight trends, BMI changes, and blood pressure improvements with GLP-1 therapy 21

The risk of bias assessment indicated that all studies had a low risk of bias

15,37 Refractory IIH was defined as either persistence of symptoms despite maximum medical therapy, progression to surgical intervention (identified through relevant CPT codes), or requirement for CSF diversion procedures or optic nerve sheath fenestration